Clinical Trial

Effect of Probiotics on Infantile Colic Symptoms

Study acronym: EPIC
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 16, 2024 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this clinical trial is to assess the impact of B. lactis B94 on participants with infantile colic. It is hypothesized that participants given the probiotic formula will have a significant reduction in their crying duration compared to participants receiving the placebo, after 4 weeks of intervention.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-04-23; most recent amendment 2024-08-14.
Status change: Not Yet Recruiting → Recruiting 2024-08-14
Trial Details
NCT Number NCT06385054
Lead Sponsor Lallemand Health Solutions
Collaborators: BioFortis
Conditions Infantile Colic
Enrollment 70 participants
Start Date 2024-08
Primary Completion 2026-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2024-08-16